← Back to Clinical Trials
Recruiting Phase 2 NCT05288790

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Trial Parameters

Condition Microtia
Sponsor Vanderbilt University Medical Center
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 250
Sex ALL
Min Age 18 Years
Max Age 89 Years
Start Date 2023-09-18
Completion 2026-08-28
Interventions
ProbioticPlacebo

Brief Summary

Among people living with HIV, heavy drinking increases the risk of heart disease and death. Studies suggest that alcohol changes the number and kind of bacteria in your gut and these changes increase the risk of heart disease and death. This randomized controlled trial will determine whether a pill containing healthy gut bacteria can increase the number good bacteria in the gut, lower levels of inflammation, and lower the risk of heart disease and death.

Eligibility Criteria

Inclusion Criteria: * HIV infected Exclusion Criteria: * Not fluent in English

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE MICROTIA TRIALS